Abstract-Several physical methods have been developed to introduce nucleic acid expression vectors into mammalian cells. Magnetic transfection (magnetofection) is one such transfection method, and it involves binding of nucleic acids such as DNA, RNA or siRNA to magnetic nanoparticles followed by subsequent exposure to external magnetic fields. However, the challenge between high efficiency of nucleic acid uptake by cells and toxicity was not totally resolved. Delivery of nucleic acids and their transport to the target cells require carefully designed and controlled systems. In this study, we introduced a novel magnetic system design providing varying magnet turn speeds and magnetic field directions. The system was tested in the magnetofection of human breast (MCF-7), prostate (DU-145, PC-3) and bladder (RT-4) cancer cell lines using green fluorescent protein DNA as a reporter. Polyethylenimine coated superparamagnetic iron oxide nanoparticles (SPIONs) were used as nucleic acid carriers. Adsorption of PEI on SPION improved the cytocompatibility dramatically. Application of external magnetic field increased intracellular uptake of nanoparticles and transfection efficiency without any additional cytotoxicity. We introduce our novel magnetism-based method as a promising tool for enhanced nucleic acid delivery into mammalian cells.
INTRODUCTION
Efficient and safe delivery of nucleic acids (DNA, RNA, siRNA etc.) into cells is critical for the development of new gene-based clinical diagnosis and treatment methods. Gene therapy is a promising and developing therapeutic method with a great potential in the treatment of various diseases, including cancer. 19 So far in order to penetrate the cell membrane barrier, viral or non-viral chemical vectors were tested alone or in combination with physical techniques. To achieve promising gene therapy, the expression or suppression level of genes is vitally important in order to preserve cellular homeostasis. Any stress-inducing factors activate a cascade of events regulated by various cellular proteins and signaling pathways and subsequently trigger genetically programmed cell death. 15 Therefore, a vector must deliver the cargo molecule to a specific intracellular target organelle, and this must be highly controlled in terms of both expression level of genes and activation of cell death. During last decades, biocompatible and biodegradable polymers have been developed as non-viral based carrier vectors and successfully used for gene delivery in various studies. 40, 46, 56, 57 As a delivery approach, magnetofection has attracted a great deal of interest because of its improving effect on gene delivery efficiency, ability to move cargo molecule to a target area under the influence of magnetic fields and the possibility of tracking using magnetic resonance imaging (MRI). Association of nucleic acids with a magnetic carrier such as polycationic superparamagnetic nanoparticles and subsequent magnetic field application is the principle behind the development of this technique. 43, 47 Magnetic field application leads to concentration of nucleic acidcoupled magnetic nanoparticles on targeted cell surfaces, and results in a significant enhancement of transfection. 14, 21, 22, 48 Further enhancement in transfection efficiency was achieved, when magnetic particles were subjected to alternating horizontal, vertical or oscillating movements of the magnetic field. 24, 37 Documentation of the advantages of magnetofection resulted in a rapid increase in the number of studies using magnetic-field mediated gene delivery. For example, transfection efficiency was successfully increased by magnetofection in primary gastric and retinal epithelial cells, 18, 26 human umbilical vein endothelial cells, 27, 39 neurons, 5, 16 cardiomyocytes, 11 myoblasts, 12 chondrocytes, fibroblasts, osteoblasts and melanocytes, 6 mouse embryonic stem cells 3 and spermatozoa cells. 25 Lee et al. showed that compared to the well established cationic liposome-based methods, magnetofection of a gene vector carrying GFP was much more efficient in mouse embryonic stem cells. 32 In an in vivo study, Kumar et al. synthesized magnetic nanoparticles coated with chitosan, and showed that magnetic exposure was sufficient to promote the internalization of GFP DNA in the heart and kidneys. 29 Another study demonstrated that application of an external magnetic field increased binding of SPIONs to cell membranes, and improved their intracellular uptake in astrocytes in culture. 31 The cellular uptake mechanism of gene delivery improvement by magnetofection was shown in several studies. Various mechanisms including unspecific endocytosis, clathrindependent and caveolae-mediated endocytic uptake were suggested. 1, 13, 22 For example, Prijic et al. showed in different malignant cells that internalization of silica-coated SPIONs were enhanced under magnetic field. 44 They found that accumulation of SPIONs in cells depended on the duration of magnetic field exposure. In addition to SPIONs, polyethylenimine (PEI)-coated SPIONs were tested in many studies of gene delivery. 9, 35 PEI is a cationic polymer, and because of its strong interaction with negatively charged nucleic acids, it is widely used as a transfection agent. 4 Several studies showed that coupling SPIONs with PEI resulted in an improved transfection efficiency compared to PEI alone 28, 54 or compared to conventional transfection agents such as lipofectamine. 8, 41, 42, 55 Chen et al. developed a PEI-DNA formulation comprising of a specific single chain antibody for targeted gene delivery into T cells. Combination of this formulation with SPIONs, led to a 16 fold of enhancement in the gene delivery efficiency of the agent. 7 Although PEI is a very efficient transfection agent, it was reported to change cell membrane and mitochondrial membrane integrity, and it was associated with cellular toxicity. 38 Therefore, development of safer and more efficient gene delivery systems with minimal toxicity and higher efficacy is still a major challenge for the success of gene therapy approaches.
Here, we designed an original and specific magnetic actuator system, which includes novel fundamental features such as controlled magnet's turn speed and magnetic field direction control, and evaluated its impact on magnetofection. For the gene delivery via magnetic actuation, we used SPIONs coupled with PEI and assessed GFP-coding vector transfection efficacy in cells derived from different tissues.
MATERIALS AND METHODS

Cells and Reagents
The pmax-GFP mammalian expression vector was supplied by Amaxa (Amaxa, Lonza, Switzerland). Branched PEI (M W 25,000) was purchased from Sigma-Aldrich (408727-USA). Dulbecco's modified Eagle's medium (DMEM) was from Sigma-Aldrich (D5671-Germany) and McCoy's 5A Medium was from PAN-Biotech (P04-05500-Germany). L-glutamine (BIO3-020-1B), Penicillin/Streptomycin (BIO3-031-1B) and Trypsin-EDTA (BIO3-050-1A) were purchased from Biological Industries (Israel). Fetal Bovine Serum (FBS) was purchased from BioWest (S1810-USA). Phosphate Buffered Saline (PBS-17-516F) without calcium or magnesium was purchased from Lonza (USA). Breast cancer (MCF-7, HTB-22), prostate cancer (PC-3, CRL-1435 and DU-145, HTB-81) and urinary bladder cancer (RT-4, HTB-2) cell lines were purchased from American Type Culture Collection (ATCC, USA).
Specific Magnetic Actuator Design
Rare earth magnets with 300 mT magnetic field strengths were placed on each face of the hexagonal profile rotors, which were actuated by a simple DC motor. The homemade system consisted of two magnetic rotors, DC motor (12 V), power switch, speed control switch, power cables, miniature gears and proper stand and units for placing cell culture dishes. In order to supply continuous magnetic field, each magnet on magnetic rotors was transversely placed.
PEI-SPION Synthesis and Characterization
PEI coated SPIONs were prepared by using a ligand exchange method. Firstly, lauric acid bilayer coated SPIONs were prepared by a co-precipitation method in aqueous medium. Simply, FeCl 3 AE6H 2 O and FeCl 2 AE4-H 2 O at mole ratio of Fe 3+ /Fe 2+ of 2 were dissolved in deoxygenated water. Lauric acid (LA) (Lauric acid/ [Fe] total = 0.5) was added to this solution under continuous nitrogen flow. Reaction mixture was heated up to 85°C and 4.5 M NH 4 OH was injected quickly under vigorous stirring. After 30 min reaction, blackbrown solution was cooled to the room temperature, providing a LA bilayer coated SPION suspension. Secondly, LA monolayer coated SPIONs were extracted from this aqueous suspension into chloroform, simply by shaking the aqueous SPIONs with fresh chloroform. Thirdly, LA-SPION suspension in chloroform was mixed and stirred with aqueous solution of branched 25 kDa PEI at room temperature for 24 h. In this process, PEI exchanges LA on the surface of SPIONs and transfer SPIONs into aqueous phase. PEI coated SPIONs were precipitated in hexane, and the precipitate was re-dissolved in water and washed for several times from 30 kDa cutoff Amicon ultrafiltration tubes with fresh DI water to remove the excess PEI. This sample was directly used for DLS (Dynamic Light Scattering) and zeta potential measurements with no further modification. Three different samples from three different batches were used for DLS and zeta potential measurements. Twelve runs per sample were performed and results were reported as an average. If outliers were detected they were excluded from the average. AFM (Atomic Force Microscopy) analysis was performed on a Bruker Dimension Icon in ScanAsyst mode in air with ScanAsyst-Air cantilever (Bruker, USA, k = 0.4 N/m, frequency 70 kHz). Samples were diluted with ethanol, sonicated and drop cast on silicon wafer for analysis. 80% of total product mass (PEI-SPION) was determined as PEI by thermo-gravimetric analysis performed on dried samples.
Plasmid DNA Isolation
Plasmid DNA isolation was performed with plasmid DNA purification kit according to manufacturer's instructions (Nucleobond Xtra Midi/Maxi, MachereyNagel, Germany). pmax-GFP plasmid was used for transfection experiments.
Cell Culture MCF-7, human breast cancer cell line, PC-3 and DU-145, human prostate cancer cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), and antibiotics (Penicillin-Streptomycin). RT-4, human urinary bladder cancer cells were cultured in McCoy's 5A complete medium supplemented with FBS and antibiotics. 1.5 9 10 6 cells were seeded on 10 cm culture plates in 10 ml cell culture medium. Cells were incubated at 37°C in a humidified incubator with a 5% CO 2 atmosphere.
Magnetofection
For all cell types, 5 lg of branched PEI or 25 lg of PEI-SPION was added into Eppendorf tubes containing 100 lL DMEM or McCoy's medium (without serum and antibiotics). In another Eppendorf tube, 2 lg of pmax-GFP was mixed with 100 lL DMEM or McCoy's medium (without serum and antibiotics). Contents of the tubes were mixed and vortexed for 15 s. Following 10 min incubation at room temperature, the mixture was added dropwise onto culture plates. Cells were concomitantly exposed to magnetic field for 6-8 h, washed with PBS and then the culture was continued in DMEM or McCoy's medium for an additional 48 h.
Microscopy Analysis and Transfection Efficiency
At 48 h post-transfection, transfection efficiency was observed under an inverted fluorescent microscope (Olympus IX70). Then cells were harvested and resuspended in PBS. Transfection efficiency was determined using a FACScan flow cytometer (Becton Dickenson, Franklin Lakes, USA). The fluorescence parameters were acquired using at least 10,000 events per sample, and three independent experiments were conducted.
Cell Viability Assays
Cancer cells transfected with PEI or PEI-SPION in the presence or absence of a static or time-varying magnetic field conditions were evaluated for cell viability. Non-transfected cells were used as control and treated in the same way as in their transfected counterparts. Cells were harvested at 48 h post-transfection and viability was assessed using the trypan blue exclusion technique. Here, loss in membrane integrity was determined by the uptake of the trypan blue dye to which cells are normally impermeable.
Statistical Analysis
Statistical analysis was performed using one-way ANOVA with Tukey's Multiple Comparison post-test (GraphPad Prism version 6, USA). Two different comparisons were done for each cell line: (1) 
RESULTS
Variable Magnetic Field Generation
Moving a magnetic field without distorting its shape is possible if the source of magnetic field can be moved in the same direction. Such a mechanism would be cumbersome. Instead, we chose to mimic the linear movement of the magnet using a set of magnets rotating around a common axis. The designed miniature magnetic actuation device generated variable magnetic fields using the synchronous rotation of symmetric and opposing magnets (Fig. 1) . In this system, reducing the angular separation of rare earth magnet pairs leads to obtain fewer discontinuities on the magnetic field, and better position tracking was ensured. This was achieved by using hexagonal rotors. As a result, the system is capable of providing magnetic fields in both vertical and horizontal directions (Fig. 2a) . Experiments were performed at a rotor turn velocity of varying 0.216 m/s, supplied voltage of 12 V, and current of 4.2 Amp. In order to assess the relationship between magnetic rotor velocity and supplied power, a voltage/current curve was constructed (Fig. 2b) . Magnetic actuation is enhanced with the rotor velocity of the set-up. Magnetic flux densities in the test sample were determined using a magnetometer. Accordingly, the magnetic flux density values varied from 30 to 300 mT, and their profile is shown in Fig. 2c .
Characterization of PEI-SPION
Hydrodynamic size of the particles was determined as 84 nm (Z-average) ( Fig. 3c ; Table 1 ). AFM (Atomic Force Microscopy) images indicate presence of 15-80 nm small aggregates with average size around 30 nm, which is somewhat close to number average measured by DLS (Figs. 3a and 3b) . These small aggregates seem to have about 8 nm height in average.
These particles posse a positively charged surface with a zeta potential of +44.6 mV, which is sufficient for colloidal stability and for gene binding. Stability of particles and resistance to aggregation in buffers and/ or biological media is important for the practical use of particles. Hydrodynamic size of PEI-SPION nanoparticles showed no significant change in a period of 1 month in DI water, NaCl, PBS and DMEM indicating stability of these particles in such mediums (Fig. S1) .
Enhancement of Transfection Efficiency by Variable
Magnetic Field PEI is one of the most successfully used polymers to obtain high transfection efficiencies for nucleic acids. To assess transfection efficiency of PEI-SPION in varying magnetic fields, we conjugated these nanoparticles with GFP-expressing DNA and transfected MCF-7, PC-3, DU-145, RT-4 cancer cells with and without magnetic field and compared transfection efficiencies (GFP fluorescent signal positive cells) with the efficiency of commercial branched PEI. As seen in Figs. 4, 5 and S2, the commercially available branched PEI was able to transfect DNA into all tested cancer cell types, and the transfection efficiency of 60% was achieved in all cancer cell lines (5 lg of PEI administration). MCF-7 cell line was resistant to transfection with PEI. Yet, we could optimize the system to obtain a 50% transfection efficiency using 5 lg of branched PEI.
PEI-SPION nanoparticles were adequate for DNA delivery to four cancer cell lines. However, the commercial PEI was more efficient than PEI-SPION in gene delivery when no magnetic field was applied. The highest efficiency with PEI-SPION was observed in all cell lines (nearly 40%). Strikingly, the gene delivery efficiency of PEI-SPION nanoparticles was significantly enhanced under the influence of the magnetic field, reaching up to 55% (Figs. 4, 5 and S2) .
We next compared cellular toxicity of PEI with that of PEI-SPION by analyzing cell viability following exposure in our experimental conditions. First of all, we observed no significant change in the viability of control cells, which were not exposed to transfection agents. Yet, the detrimental effects of PEI were observed when compared to control cells, indicating a high level of toxicity of PEI in all tested cell lines (Fig. 6) . Comparison of the toxicity of commercial PEI with that of PEI-SPION showed a quite remarkable and significant difference: PEI coated SPION was clearly less toxic than the commercial PEI, and the toxicity was not further increased after variable magnetic field application (Fig. 6) . Similar toxicity patterns were observed in all tested cell lines indicating that, independent from the cell type used, PEI-SPION nanoparticles are efficient and safer gene delivery tools compared to commercial PEI preparations.
DISCUSSION
Although, viral and non-viral chemical vectors are the favored delivery method in gene therapy, they can have adverse consequences. Adenoviral vectors may be toxic and induced inflammatory immune responses, which can lead to patient death. 10 Besides, retroviral vectors carry high risks so that insertional mutagenesis leads to malignant transformation. 52 In addition to their biosafety concerns, viral vectors have a limited packaging capacity for incorporation of exogenous DNA. Compared to viral vectors, non-viral chemical vectors provide some benefits; however efficiency and targeting are the major limitations, particularly in some specific cell types.
Recent advances in the nanotechnology field allowed the development of nanoparticle-based new tools that might be used in the diagnosis, treatment and prevention of human health problems. Because of their many advantages, magnetic nanoparticles have become one of the most popular nano-particle based tools in gene delivery. They can be designed and modified easily, and in living cells they have high carrying efficiency without inducing immunogenicity. 2 Transfection of nucleic acids using superparamagnetic iron oxide nanoparticles (SPION) utilizing the cationic polymer, PEI, as a coating is an effective method to manipulate or modify the function of genes in cells. Thus, this method has been increasingly studied to overcome the limitations of conventional technology such as electroporation or viral transfection. 53 For a successful adaptation of SPIONs in therapy and utilization of its response to an external magnetic field to achieve effective localization in target tissue, application of suitable magnetic field gradients is required. Applied magnetic forces should be strong enough to overcome blood flow resistance in the arteries, 36 and hence, it is critically important to design a safe and efficient magnetic field actuator devices for both in vitro and in vivo applications. In the present study, we generated an original magnetic actuator device with defined magnet's turn speeds and magnetic field directions and showed its successful proof-of-concept usage in SPION-mediated gene delivery into different cell types. Indeed, in our study we showed that magnetic manipulation of PEIcoated SPION could efficiently deliver genes into cell lines of different tissue origins, and the method was associated with lower toxicity compared to conventional PEI-mediated transfections. To our knowledge, this study is among the first reports to implement such a system in the in vitro transfection of cells, including MCF-7, PC-3, DU-145 and RT-4 cells.
Oscillating magnet arrays were shown to offer advantages over static magnets in the enhancement of magnetofection in some cell types. 37, 51 The effect of oscillating magnetic fields on the transfection efficiency using a range of frequencies and amplitudes was investigated in mouse embryonic fibroblasts (MEF), human umbilical vein endothelial cells (HUVEC), 33 rat oligodendrocyte precursor cells, 23 rat astrocytes and MG63 cells. 17 In these studies, researchers suggested that magnetofection depended on the versatility of the frequency-displacement. However, the reason behind frequency-displacement dependent transfection remains elusive. In another study, an orbital rotation of cylindrical permanent magnet was used to create dynamic gradient magnetic fields. 51 The authors compared the transfection efficiency that was obtained by liposomal magnetofection to standard magnetofection in PC-3 cells. Highest transfection efficiency was obtained using liposomal magnetofection under dynamic gradient magnetic fields when compared to permanent magnetic fields. Different from studies cited above, in our study, we generated varying magnetic fields using the synchronous rotation of symmetric and opposing magnets, which was inspired by the promising results of a similar concept used in micropumping and heat transfer enhancement in our previous studies. 30, 49 Here, we report on a novel system using hexagonal rotors to provide magnetic fields in both vertical and horizontal directions (Fig. 2a) . The advantage of our design is that magnetic field peaks when the magnets are at the closest position, and it diminishes when the magnets are at the farthest position. For this, the actuator rotor speed was adjusted by varying the current, and as a result, significant rotor velocities (> 0.1 m/s) were achieved up to a maximum velocity (0.126 m/s), which is the limit of the current rotor (Fig. 2b) . The rotor velocity imposes variation of magnetic flux density in the system. Accordingly, the bigger the rotor velocity is, the faster the magnetic flux density variation occurs (Fig. 2c) . For human cells used in this study, highest transfection efficiency was achieved with this system in the presence of both vertical and horizontal magnetic fields (Figs. 4, 5 and S2) .
In our study, we used ultrasmall SPIONs (84 nm) coated with 25 kDa branched PEI, providing a positively charged surface and offering stability in biologically and physiologically relevant solutions and media, such as NaCl, PBS and DMEM (Fig. S1 ). Stability in these aqueous environments is important to prevent particle aggregation before and during the preparation of gene/SPION complex and during the incubation with cells.
Surface modifications with polyethylene glycol (PEG) or polyacrylic acid (PAA) or combination of them with a cationic polymer, PEI, was reported to improve transfection quality of SPIONs. 51 It has been previously shown that PEG-PEI-SPION or B-(branched)-PEI-SPION complexes enhanced transfection efficiency compared to lipofectamine or the only PEI case when magnetic field was applied to SGC-7901 human gastric carcinoma 8, 9 or NIH3T3 mouse embryonic fibroblast and PC-3 human prostate cancer cell line. 39 By using PAA-PEI-SPION, similar transfection studies have been performed and reported high transfection efficiencies in human (SK-MEL-28) and mouse (B16F1) malignant melanoma, normal human mesothelial (MeT-5A) and mouse fibroblast (L929) cell lines. 45 In our study, we observed that PEI-SPION transfection efficiency was increased in breast cancer (MCF-7), prostate cancer (PC-3 and DU-145) and bladder cancer (RT-4) cell lines in the presence of both vertical and horizontal magnetic fields when compared to the without magnetic field case.
Iron oxide nanoparticles were shown to degrade through natural iron metabolism pathways of the body, where irons are incorporated into the he- , prostate cancer (PC-3 and DU-145) and bladder cancer (RT-4) cell lines were transfected with GFP-expressing DNA using PEI or PEI-SPION under steady (no variation) and variable magnetic or non-magnetic conditions. 48 h post-transfection cell viability was evaluated by trypan blue exclusion assay. The relative percentage of the control cells, which were not exposed to the transfection agent, was used to represent cell viability without any treatment. Data were shown as mean 6 SD of 3 independent experiments (n 5 3 and *p < 0.05).
moglobin pool. 20 Nevertheless, large surface area to volume ratio makes SPIONs predisposed to reaction with other molecules, which could lead to enhanced toxicity. 50 Hence, coating of SPIONs with an appropriate materials is crucial to prevent toxic effects. 37 On the other hand, several studies reported a decrease in the toxicity of PEI when deposited on SPIONs. 53 In Fig. 6 , we showed that PEI-SPION/DNA was less toxic than PEI/DNA at doses used for the transfection experiments, 25 vs. 5 lg, respectively. In 25 lg of PEI-SPION there is about 20 lg of PEI, and this amount would be well below LD50 for these cells unless PEI was adsorbed on the SPION surface. This indicates an important advantage of PEI-SPION formulation. Binding PEI to SPION surface actually decreases the amount of free primary amine groups, which possibly has a positive impact on cytocompatibility of these particles. Interestingly, exposure to the magnetic field did not cause any additional cytotoxicity in any of the studied cell types, and in the contrary, it improved cell survival during and after gene delivery. This may indicate that internalized dose of nanoparticles are not at significant toxicity level which is highly advantageous for a delivery system.
Although variable magnetic field produced a significant enhancement of transfection efficiency of PEI-SPION, it is still similar or slightly lower than PEI. However, one should remember that PEI-SPION holds a great cytocompatibility advantage and this transfection efficiency can be improved further. There may be several reasons for no dramatic improvement of transfection efficiency over PEI, here: (1) since part of the amines is bound on the surface of SPION, available amines for the GFP binding are less, which may result in less GFP per gram formulation. (2) unequal N/P ratio. These transfection efficiencies most probably were further enhanced in a detailed transfection study based on N/P ratio. Considering the PEI amount, more GFP may be loaded to the nanoparticles and/or more nanoparticles can be used. However, the focus of this presented work is the evaluation of the newly developed magnetic system in magnetofection and to determine its advantages in enhancing transfection with respect to conventional systems. Therefore, it was tested on different cell types at doses, in which successful transfections were achieved. In summary, the obtained results strongly support the use of variable (both vertical and horizontal) magnetic fields as a viable tool for enhanced PEI-SPION magnetofection of genes into cancer cell lines.
In this study, a platform for gene delivery via magnetic actuation of nanoparticles was developed. PEI-SPION was investigated as a transfection agent in in vitro studies using varying magnetic fields provided by a miniature device. The proposed device could be used as a magnetic actuator in various systems, providing modulable magnet's turn speed and directions. The major findings of this study are as follows: 1. It is demonstrated that the miniature magnetic actuator setup could be used for the investigation of SPIONbased transfection agents in in vitro systems. 2. PEI-SPION nanoparticles can be successfully used for nucleic-acid based gene delivery in cells-derived from different tissues [i.e., MCF-7 (breast), PC-3 (prostate), DU-145 (prostate), RT-4 (bladder)], and magnetic field exposure can improve the delivery efficiency significantly. 3. In the presence of both vertical and horizontal magnetic fields generated by the magnetic actuation system of this study, higher transfection efficiencies and lower toxicities were attained with PEI-SPION nanoparticles. 4. It is proven that the miniature magnetic actuator could deliver genes to the targeted cells with low energy consumption and enhanced safety. 5. Potential use of the device in in vivo studies aiming at gene and possibly drug delivery to whole organisms might be feasible. While magnetofection has many practical applications in cell culture, it may someday be used in patients. With the introduction of nanoparticles as drug and gene carriers, novel gene therapy strategies are being developed, and some strategies even reached clinical trials. 19, 34 Using the advantage of magnetic manipulation properties of SPIONS, the current set-up inspires hope for accurate and efficient delivery of genes for therapeutic purposes. Our study and others provide a proof-of-concept for further studies and clinical applications. Human scale treatments using electromagnetism and magnetic coils might be tested for therapy purposes. Alternatively, MRI hardware may be adapted to provide magnetic field with necessary characteristics. Further studies of optimization and improvement of the system for in vivo conditions might allow the use of the system in clinics and hospitals in the near-future.
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